INFORMATION FROM THE EPO
Representation of nucleotide and amino acid sequences in patent applications and filing of sequence listings
Supplement No. 2 to this edition of the Official Journal contains a decision of the President of the EPO as well as a notice from the European Patent Office concerning the representation of nucleotide and amino acid sequences in patent applications and the filing of sequence listings.
The supplement will be forwarded separately to the subscribers of the Official Journal.